Michael Wagels

Dr. Michael Wagels serves as Clinical Director of the Herston Biofabrication Institute (since August 2020) and Staff Specialist in Plastic and Reconstructive Surgery, including paediatric surgery, at Queensland Children's Hospital. He concurrently directs the Australian Centre for Complex Integrated Surgical Solutions (ACCISS) at the Translational Research Institute, affiliated with The University of Queensland.

His academic foundation includes a Bachelor of Medical Science (BMedSci) and Bachelor of Medicine/Bachelor of Surgery (MBBS) completed in 1999, Fellowship of the Royal Australasian College of Surgeons (FRACS) in Plastic and Reconstructive Surgery (2012), and a PhD from The University of Queensland (2014) investigating amputation in severe lower limb trauma and auto-transplanted muscle behavior for traumatic injuries.

Wagels' research focuses on translational tissue engineering for complex reconstructive defects, with specialization in scaffold-guided regeneration for bone and breast reconstruction using 3D printing. His clinical expertise spans complex lower limb reconstruction, hand and wrist surgery, craniofacial reconstruction, and upper limb reanimation. He pioneered Regenerative Matching Axial Vascularisation techniques through three first-in-human trials of patient-specific bioresorbable implants for large bone defects and soft tissue contour deformities.

Analysis of his 2023-2025 publications reveals dominant themes in scaffold-guided tissue engineering, particularly for load-bearing bone defects and breast reconstruction. His work integrates biomechanical evaluation of 3D-printed scaffolds, preclinical large animal models, and clinical trial design, emphasizing translational pathways from bench to bedside. Key innovations include medical-grade polycaprolactone implants, corticoperiosteal tissue transfer techniques, and augmented reality surgical planning.

No scientific awards were explicitly documented in the source materials.

While specific grant details and student mentorship records weren't provided, Wagels leads ACCISS and the Herston Biofabrication Institute—multidisciplinary hubs driving clinical translation of biofabrication technologies through industry-academic partnerships and collaborative research frameworks.

He directs the Australian Centre for Complex Integrated Surgical Solutions (ACCISS) at TRI and the Herston Biofabrication Institute, both serving as innovation engines for surgical solutions through engineer-clinician collaboration. These entities facilitate first-in-human trials, regulatory navigation for 3D-printed medical devices, and development of biodegradable patient-specific implants for craniofacial, orthopedic, and breast reconstruction applications.